Top Markets
#1 Helium Helium +47.19%
#2 TENDIES TENDIES +38.25%
#3 Pons Pons +34.88%
#4 Seeker Seeker +18.73%
#5 UnifAI Network UnifAI Network +16.40%
#6 StonkBroker StonkBroker +14.84%
#7 Songbird Songbird +12.07%
#8 Lista DAO Lista DAO +11.75%
#9 OSK OSK +10.10%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +10.01%
Coin of the day
Helium Helium
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
Clasificación en acciones #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Precio por acción
$26.13
Última sincronización: 2026-08-28
Capitalización bursátil
$873.45M
Cambio (1 día)
-2.99%
Cambio (1 año)
-
País
US
Comercio SpyGlass Pharma, Inc. Common Stock (SGP)

Categoría

Healthcare
Ratio P/S de SpyGlass Pharma, Inc. Common Stock (SGP)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de SpyGlass Pharma, Inc. Common Stock, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de SpyGlass Pharma, Inc. Common Stock desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH